Masimo O3 5 Aug.jpg” />

US-based medical technology company Masimo has obtained the CE mark for its O3 regional oximetry with the O3 pediatric sensor.

Regional oximetry, also known as issue or cerebral oximetry, assists clinicians in monitoring cerebral oxygenation and detecting regional hypoxemia.

The mechanism of the O3 regional oximetry uses near-infrared spectroscopy (NIRS) and reflectance pulse oximetry for a continuous monitor of absolute and trended regional tissue oxygen saturation (rSO2) in the cerebral region.

It results in an early detection, fixing the unproportionate delivery of oxygen to the brain and vital organs thereby helping patients avoid postoperative morbidity and adverse outcomes.

The introduction of the O3 pediatric sensor expands the availability of the O3 regional oximetry monitoring of rSO2 for pediatric patients weighing less than 40kg (88lbs).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"O3 regional oximetry provides access to valuable data about cerebral oxygen saturation."

Masimo founder and CEO Joe Kiani said: “O3 regional oximetry provides access to valuable data about cerebral oxygen saturation, and studies have shown that the risks of cerebral desaturations include neurological injury, increased length of hospital stays, increased time on mechanical ventilation, and other adverse outcomes.

“With adult trend accuracy of 3% and absolute accuracy of 4% without controlling CO2, and trend accuracy of 3% in pediatric patients, Masimo O3 should help clinicians build a better picture of brain oxygenation and hopefully better outcomes for all of their patients, including pediatric ones.”

Masimo’s O3 regional oximetry and SedLine brain function monitoring operate on a single platform, Masimo Root.


Image: Masimo Root with SedLine and O3 with Pediatric Sensor. Photo: courtesy of Masimo.